Modeling of the pharmacokinetic/pharmacodynamic interaction between irbesartan and hydrochlorothiazide in normotensive subjects

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-081x|36|4|216-231

ISSN： 0142-2782

Source： Biopharmaceutics And Drug Disposition, Vol.36, Iss.4, 2015-05, pp. : 216-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic-Pharmacodynamic Investigation of a Possible Interaction Between Steady-State Temocapril and Warfarin in Healthy Subjects

By Lankhaar G.

Clinical Drug Investigation, Vol. 17, Iss. 5, 1999-05 ,pp. : 399-405

Adis International

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacodynamic Interaction between Allopurinol and Probenecid in Healthy Subjects

By Stocker Sophie L. Williams Kenneth M. McLachlan Andrew J. Graham Garry G. Day Richard O.

Clinical Pharmacokinetics, Vol. 47, Iss. 2, 2008-01 ,pp. : 111-118

Adis International

Access to resources Recommend Favorite

Evaluation of the Potential Pharmacokinetic/Pharmacodynamic Interaction between Fluoxetine and Reboxetine in Healthy Volunteers

By Fleishaker J.C.

Clinical Drug Investigation, Vol. 18, Iss. 2, 1999-08 ,pp. : 141-150

Adis International

Access to resources Recommend Favorite

Pharmacokinetic-Pharmacodynamic Interaction between Nebicapone, a Novel Catechol-O-Methyltransferase Inhibitor, and Controlled-Release Levodopa/Carbidopa 200 mg/50 mg: Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects

By Vaz-da-Silva Manuel

Drugs in R&D, Vol. 9, Iss. 6, 2008-01 ,pp. : 435-446

Adis International

Access to resources Recommend Favorite

Pharmacokinetic/Pharmacodynamic Modeling of GLP-1 in Healthy Rats

By Cao Yanguang Gao Wei Jusko William

Pharmaceutical Research, Vol. 29, Iss. 4, 2012-04 ,pp. : 1078-1086

Springer Publishing Company

Access to resources Recommend Favorite